Cefalosporinok alkalmazása puerperalis metritises és endometritises tejelo′ tehenek gyógykezelésére*

Translated title of the contribution: Use of cephalosporins for the treatment of dairy cows suffering of puerperal metritis and endometritis

Földi József, Pécsi Anna, J. Szabó, Pécsi Tamás, Bruno Huyghe, Carlos De Sa, Peter Cox, M. Kulcsár, G. Huszenicza

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Summary. A clinical study was performed including 265 diseased cows in 9 dairies to test the efficacy of the systemic administration of a 3rd generation (ceftiofur, injectable) and the local application of a 4th generation (cefquinome, intrauterine suspension) cefalosporine for the treatment of bovine puerperal metritis (PM). Both products were used after establishing the diagnosis of PM, typically on days 8-14 post partum. Ceftiofur was injected in a dose of 1 ml/kg bw daily for 5 consecutive days, while cefquinome 900 mg suspension was administered once for each cow and the treatment was repeated 72 hours later in 60% of the animals on clinical assessment. A meta-analysis of three recently published studies of the authors on cefapirine and prostaglandine F2a (PGF2α) treated cows with clinical endometritis (EM) on days 28-35 post partum was performed, as compared to untreated control group. Products were administered once or twice with 7 days interval on clinical assessment. Single parameter of the studies was the re-conception rate. A fixed effect model was used for the metaanalysis, since each study separately also revealed a certain, although not significant effect of the treatments. Odds ratios (OR) and their 95% confidence interval (CI) for each trial, as well as the pooled OR and CI 95% were calculated. Hypothesis testing was done according to Mantel-Haenszel and Peto-Yusuf methods. Pooled relative risk (RR) for re-conception was 1.3 in the cefapirine treated groups as compared to the control, while OR was 1.9, (CI 95% 1.16-3.12) proved to be significant (p=0,0104). Pooled RR for pregnancy of the PGF2α treated cows was 1.2, odds ratio 1.5, (CI 95% 1.03-2.30), which revealed also significant difference (p=0.0306). The generally good sensitivity of Arcanobacterium pyogenes, the most important causative agent of EM to cefapirin allows the effective use of this 1st generation cephalosporin for the therapy of EM. PGF2a7alpha; can also be efficacious, because 4-5 weeks post partum high proportion of cows already have cyclic ovarian activity.

Original languageHungarian
Pages (from-to)451-455
Number of pages5
JournalMagyar Allatorvosok Lapja
Volume131
Issue number8
Publication statusPublished - 2009

Fingerprint

Endometritis
cephalosporins
endometritis
Cephalosporins
dairy cows
odds ratio
Odds Ratio
Confidence Intervals
confidence interval
cows
ceftiofur
relative risk
Suspensions
Cephapirin
Arcanobacterium
Therapeutics
Arcanobacterium pyogenes
Meta-Analysis
conception rate
meta-analysis

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Cefalosporinok alkalmazása puerperalis metritises és endometritises tejelo′ tehenek gyógykezelésére*. / József, Földi; Anna, Pécsi; Szabó, J.; Tamás, Pécsi; Huyghe, Bruno; De Sa, Carlos; Cox, Peter; Kulcsár, M.; Huszenicza, G.

In: Magyar Allatorvosok Lapja, Vol. 131, No. 8, 2009, p. 451-455.

Research output: Contribution to journalArticle

József, Földi ; Anna, Pécsi ; Szabó, J. ; Tamás, Pécsi ; Huyghe, Bruno ; De Sa, Carlos ; Cox, Peter ; Kulcsár, M. ; Huszenicza, G. / Cefalosporinok alkalmazása puerperalis metritises és endometritises tejelo′ tehenek gyógykezelésére*. In: Magyar Allatorvosok Lapja. 2009 ; Vol. 131, No. 8. pp. 451-455.
@article{9c8da6a18e6c48c896a55cc519aa2b18,
title = "Cefalosporinok alkalmaz{\'a}sa puerperalis metritises {\'e}s endometritises tejelo′ tehenek gy{\'o}gykezel{\'e}s{\'e}re*",
abstract = "Summary. A clinical study was performed including 265 diseased cows in 9 dairies to test the efficacy of the systemic administration of a 3rd generation (ceftiofur, injectable) and the local application of a 4th generation (cefquinome, intrauterine suspension) cefalosporine for the treatment of bovine puerperal metritis (PM). Both products were used after establishing the diagnosis of PM, typically on days 8-14 post partum. Ceftiofur was injected in a dose of 1 ml/kg bw daily for 5 consecutive days, while cefquinome 900 mg suspension was administered once for each cow and the treatment was repeated 72 hours later in 60{\%} of the animals on clinical assessment. A meta-analysis of three recently published studies of the authors on cefapirine and prostaglandine F2a (PGF2α) treated cows with clinical endometritis (EM) on days 28-35 post partum was performed, as compared to untreated control group. Products were administered once or twice with 7 days interval on clinical assessment. Single parameter of the studies was the re-conception rate. A fixed effect model was used for the metaanalysis, since each study separately also revealed a certain, although not significant effect of the treatments. Odds ratios (OR) and their 95{\%} confidence interval (CI) for each trial, as well as the pooled OR and CI 95{\%} were calculated. Hypothesis testing was done according to Mantel-Haenszel and Peto-Yusuf methods. Pooled relative risk (RR) for re-conception was 1.3 in the cefapirine treated groups as compared to the control, while OR was 1.9, (CI 95{\%} 1.16-3.12) proved to be significant (p=0,0104). Pooled RR for pregnancy of the PGF2α treated cows was 1.2, odds ratio 1.5, (CI 95{\%} 1.03-2.30), which revealed also significant difference (p=0.0306). The generally good sensitivity of Arcanobacterium pyogenes, the most important causative agent of EM to cefapirin allows the effective use of this 1st generation cephalosporin for the therapy of EM. PGF2a7alpha; can also be efficacious, because 4-5 weeks post partum high proportion of cows already have cyclic ovarian activity.",
author = "F{\"o}ldi J{\'o}zsef and P{\'e}csi Anna and J. Szab{\'o} and P{\'e}csi Tam{\'a}s and Bruno Huyghe and {De Sa}, Carlos and Peter Cox and M. Kulcs{\'a}r and G. Huszenicza",
year = "2009",
language = "Hungarian",
volume = "131",
pages = "451--455",
journal = "Magyar Allatorvosok Lapja",
issn = "0025-004X",
publisher = "Magyar Mezogazdasag Ltd",
number = "8",

}

TY - JOUR

T1 - Cefalosporinok alkalmazása puerperalis metritises és endometritises tejelo′ tehenek gyógykezelésére*

AU - József, Földi

AU - Anna, Pécsi

AU - Szabó, J.

AU - Tamás, Pécsi

AU - Huyghe, Bruno

AU - De Sa, Carlos

AU - Cox, Peter

AU - Kulcsár, M.

AU - Huszenicza, G.

PY - 2009

Y1 - 2009

N2 - Summary. A clinical study was performed including 265 diseased cows in 9 dairies to test the efficacy of the systemic administration of a 3rd generation (ceftiofur, injectable) and the local application of a 4th generation (cefquinome, intrauterine suspension) cefalosporine for the treatment of bovine puerperal metritis (PM). Both products were used after establishing the diagnosis of PM, typically on days 8-14 post partum. Ceftiofur was injected in a dose of 1 ml/kg bw daily for 5 consecutive days, while cefquinome 900 mg suspension was administered once for each cow and the treatment was repeated 72 hours later in 60% of the animals on clinical assessment. A meta-analysis of three recently published studies of the authors on cefapirine and prostaglandine F2a (PGF2α) treated cows with clinical endometritis (EM) on days 28-35 post partum was performed, as compared to untreated control group. Products were administered once or twice with 7 days interval on clinical assessment. Single parameter of the studies was the re-conception rate. A fixed effect model was used for the metaanalysis, since each study separately also revealed a certain, although not significant effect of the treatments. Odds ratios (OR) and their 95% confidence interval (CI) for each trial, as well as the pooled OR and CI 95% were calculated. Hypothesis testing was done according to Mantel-Haenszel and Peto-Yusuf methods. Pooled relative risk (RR) for re-conception was 1.3 in the cefapirine treated groups as compared to the control, while OR was 1.9, (CI 95% 1.16-3.12) proved to be significant (p=0,0104). Pooled RR for pregnancy of the PGF2α treated cows was 1.2, odds ratio 1.5, (CI 95% 1.03-2.30), which revealed also significant difference (p=0.0306). The generally good sensitivity of Arcanobacterium pyogenes, the most important causative agent of EM to cefapirin allows the effective use of this 1st generation cephalosporin for the therapy of EM. PGF2a7alpha; can also be efficacious, because 4-5 weeks post partum high proportion of cows already have cyclic ovarian activity.

AB - Summary. A clinical study was performed including 265 diseased cows in 9 dairies to test the efficacy of the systemic administration of a 3rd generation (ceftiofur, injectable) and the local application of a 4th generation (cefquinome, intrauterine suspension) cefalosporine for the treatment of bovine puerperal metritis (PM). Both products were used after establishing the diagnosis of PM, typically on days 8-14 post partum. Ceftiofur was injected in a dose of 1 ml/kg bw daily for 5 consecutive days, while cefquinome 900 mg suspension was administered once for each cow and the treatment was repeated 72 hours later in 60% of the animals on clinical assessment. A meta-analysis of three recently published studies of the authors on cefapirine and prostaglandine F2a (PGF2α) treated cows with clinical endometritis (EM) on days 28-35 post partum was performed, as compared to untreated control group. Products were administered once or twice with 7 days interval on clinical assessment. Single parameter of the studies was the re-conception rate. A fixed effect model was used for the metaanalysis, since each study separately also revealed a certain, although not significant effect of the treatments. Odds ratios (OR) and their 95% confidence interval (CI) for each trial, as well as the pooled OR and CI 95% were calculated. Hypothesis testing was done according to Mantel-Haenszel and Peto-Yusuf methods. Pooled relative risk (RR) for re-conception was 1.3 in the cefapirine treated groups as compared to the control, while OR was 1.9, (CI 95% 1.16-3.12) proved to be significant (p=0,0104). Pooled RR for pregnancy of the PGF2α treated cows was 1.2, odds ratio 1.5, (CI 95% 1.03-2.30), which revealed also significant difference (p=0.0306). The generally good sensitivity of Arcanobacterium pyogenes, the most important causative agent of EM to cefapirin allows the effective use of this 1st generation cephalosporin for the therapy of EM. PGF2a7alpha; can also be efficacious, because 4-5 weeks post partum high proportion of cows already have cyclic ovarian activity.

UR - http://www.scopus.com/inward/record.url?scp=69549108966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69549108966&partnerID=8YFLogxK

M3 - Article

VL - 131

SP - 451

EP - 455

JO - Magyar Allatorvosok Lapja

JF - Magyar Allatorvosok Lapja

SN - 0025-004X

IS - 8

ER -